Hannah Devlin, Science Correspondent for The Guardian, reports on a path breaking planned trial focusing on whether diet can improve the effectiveness of cancer drugs. Led by Dr. Siddhartha Mukherjee, one of the world’s leading oncologists, the study will center on the impact of a high-fat, low-carbohydrate diet and whether there could be a positive correlation for patients with lymphoma and endometrial cancer.
Interestingly, the study represents one of others planned by an international working group on “rethinking human diets for cancer.” This study is anchored by recent lab work by Mukherjee and published in Nature. https://www.nature.com/articles/s41586-018-0343-4
In the study patients are treated with Aliqopa, a licensed drug manufactured by German pharmaceutical company Bayer. https://www.hcp.aliqopa-us.com/. Aliqopa has been limited in certain cases but Mukherjee and the Columbia study team believe it could be effective when introduced with dietary changes aimed at decreasing insulin levels. Individuals interested lymphoma and endometrial cancer research in specific and oncology generally should keep an eye on this trial. Additionally TrialSite News maintains the largest data base of clinical research site and their staff worldwide. Bookmark the site to keep up on similar research. We provide a link to Mukherjee here. http://cancer.columbia.edu/siddhartha-mukherjee-md-dphil
View article hereSource: The Guardian